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DIESSELHOFF-DEN DULK
(From theDepartment of Microbial Diseases, University Hospital, Leiden, The Netherlands)
Azathioprine (Imuran®) has been shown to cause a reduction in the number of monocytes
in the peripheral blood, the rate and extent ofthe reduction being related to the dose of the
drug and the duration of its administration . A high dose ofazathioprine-daily 200 mg/kg,
which is the maximum tolerated dose in mice-administered over a period of 9 days,
causes an almost complete reduction of the circulating monocytes ; this effect is reversible,
because when treatment is stopped the number of monocytes start to increase 24-48 h
later.' Daily administration of a low dose (3 mg/kg), which is about equivalent to a
nontoxic, immunosuppressive, anti-inflammatory dose in man, results after 9 days in a
reduction of about 50% in the number of monocytes .' The number of peritoneal
macrophages, however, only decreases when a high dose of the drug is given over a longer
period; a low dose has virtually no effect.'
Azathioprine also suppresses the acute inflammatory reaction in that the numbers of
monocytes in the peripheral blood and macrophages at the site of inflammation show
virtually none of the increase that would normally occur in the absence of the drug. The
extent of this anti-inflammatory action is also dependent on the dose of azathioprine
administered.'
Labeling studies with ['H]thymidine indicated that azathioprine inhibits the forma-
tion of monocytes both during the normal steady state and in an acute inflammatory
response. Because azathioprine is an antimetabolite interfering with DNA synthesis (1, 2),
it can be expected to inhibit the mitotic activity of the direct precursor of the monocyte in
the bone marrow, the promonocyte. Since the kinetic parameters of the promonocytes in
normal mice are known in great detail, this problem could be approached directly (3, 4) .
The present report describes the effect of azathioprine on the mitotic activity of the
promonocytes and the quantitative aspects of monocyte production during azathioprine
treatment.
* This study was partially supported by the Foundation for Medical Research FUNGO, which is
subsidized by The Netherlands Organization for the Advancement of Pure Research (ZWO).
t Present address: Department of Surgery, University of Bern Tiefenauspital, Bern, Switzerland.
' Gassmann, A. E., and R. van Furth. 1975. The effect of azathioprine (Imuran®) on the kinetics o°
monocytes and macrophages during the normal steady state and acute inflammatory reaction.
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EFFECT OF AZATHIOPRINE ON THE CELL CYCLE OF PROMONOCYTES
Animals. This investigation was done in specific pathogen-free male Swiss mice (25-30 g)
obtained from the Central Institute for the Breeding of Laboratory Animals, TNO, Bilthoven, The
Netherlands.
Aaathioprine and 6-Mercaptopurine. Azathicprine (Imuran, 50-mg vials, freeze dried) was kindly
provided by Burroughs Wellcome & Co., London, England. Immediately before use, 5ml pyrogen-free
distilledwater was added to the vial. When necessary, further dilutions were made such that thevol
to be injected was always 0.5 ml. The drug was administered subcutaneously in thenuchal region at
intervals of 24 hunless otherwise stated. Thedosesappliedwere 200, 100, 50, or 3mg/kgbody weight.
6-mercaptopurine (Burroughs Wellcome & Co.) was used only for in vitro experiments. A fresh
stocksolution (3,000 ;ig/ml) was prepared daily by dissolving 6-mercaptopurine in 0.1 ml 1 N NaOH
and 0.8 ml medium 199 (Microbiological Associates Inc., Bethesda, Md.). The stock solution was
further diluted with medium 199 before addition to the culture medium.
Bone Marrow Cultures. The methods used to obtain bone marrow samples, prepare cell
suspensions, and culture these cells, have been described in detail elsewhere (3-5). Cell suspensions
made from the bone marrow of individual femurs were processed separately. The culture medium
consisted of medium 199, 20% newborn calf serum (NBCS)' (Grand Island Biological Co., Grand
id, N. Y.), 200 U/ml penicillin G, and 50 teg/ml streptomycin. The cell suspensions were first
d in aLeighton tube for 2 hto allow the cells to attach to the cover slip. Afterthe supernate
oved andthe cell layeron the coverslip washed threetimesby vigorous shakingin 1.5 ml
ed again with 2 ml culture medium for an additional 4h.
time of6h, thecellson thecoverslip were washed again threetimes, quickly
ried, and fixed for 30 min in absolute methyl alcohol.
Bone Marrow Cell Counts.
￿
The total number of nucleated cells per femur was counted in the
bone marrow cell suspension (diluted 1:20with Turk's solution containing 6% acetic acid) in aBiirker
hemocytometer. The total number of monocytes per femur was calculated from the total number of
nucleated cells in the bone marrow cell suspension and the percentage of monocytes which was
obtained from differential counts of 200nucleated bone marrow cellsin Giernsa-stained preparations
made with a sedimentation apparatus (6). The total number of promonocytes per femur was
computed with the promonocyte-to-monocyte ratio determined in 6-h bone marrow culture
preparations and the total number of bone marrow monocytes.
Foreach mouse, cell counts were done in both femurs; the values given per femurrepresentthe
meansof four mice.Sincein mice the bone marrow of twofemurs accounts for 11.8% of thetotalbone
marrow mass (7), thetotalnumber ofpromonocytes andmonocytesper mousecould be calculated.
Peripheral Blood Monocytes.
￿
Monocytes of the peripheral blood were studied in tail-vein blood
as describedin an earlierpaper(4).Thebloodvolof mice weighing 25 gis about3ml (8), andthetotal
number of peripheral blood monocytes per mouse was calculated on this basis.
Labeling with ['H]Thymidine.
￿
In vitro labeling of mononuclear phagocytes was performed by
ubating thebone marrow cellsfor6 h in medium containing 0.1,Ci/ml ['H]thymidine (sp act 6.7
ol; New England Nuclear Corp., Boston, Mass.). To avoid underestimation of the mitotic
activity, the medium used for harvesting the bone marrow also contained ['H]thymidine. The
cultures were processed and prepared for autoradiography as described elsewhere (3).
In vivo labeling wasdone by one intravenous injection of 1 pCi/gbody weight [sH]thymidine into a
tail vein . The bone marrow samples harvested at the chosen time points were cultured for 6 h in a
nonradioactive culture medium and prepared for autoradiography as already described (3).
The labeling index at each time point represents the mean value of four mice obtained in two
femurs. Thetotalnumbersof labeled promonocytes and monocyteswere calculated with thevaluesof
the labeling i
Autoradiography.
elsewhere (5).
Cytophotometric Measurement of Nuclear DNA of Promonoeytes and Bone Marrow Mono-
cytes. Bone marrow cell suspensions were cultured for 6 h, washed, quickly air dried, and fixed
with absolute methanol for 15 min at room temperature, followed by postfixation in 4% formaldehyde
Materials and Methods
s per mouse.
staining of the developed slides were as described
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solution for 2 h. Afterthe cellson the cover slip had been stained according to a Feulgentechniquefor
quantitative purposes, the DNA content of the nuclei was determined cytophotometrically with an
integrating microdensitometer of the Deeley type (Barr and Stroud, Glasgow, England) at 5,600 A,
using an oil-immersion fluorite objective (40x, numerical aperture 0.75) as described by James (9).
On each slide the nuclei of 20 granulocytes, 20 monocytes, and 40 promonocytes were measured.
As a referencefor the diploid value, we used the Feulgen DNA content of the granulocytes on the
same slide. The mean values oftheFeulgen-DNAcontentofgranulocytes andmonocytes were similar
(SDless than 5%). With the mean valueobtained for themonocytes, theFeulgen-DNAcontentofthe
promonocyte nuclei was calculated for each slide and expressed in arbitrary units (AU) . The mean
diploid value was taken, via a correction factor, as 100 AU; all readings were multipled by the same
correction factor. Cells with aFeulgen-DNAcontent of 100 AU t 2 SD are considered diploid, and
cells with tetraploid values of Feulgen-DNA will lie within 200 AU t 2 SD.
Calculation of Monocyte Production. The total production of monocytes was calculated as
described previously (4) with the equation:
Po-r = (Ibm x Nbm)t t (Ib) x NbOt - (Ib, xNb,)t-~ -F kfbe (Ib, xNb,)t dt,
in whichPo-, = totalnumber of labeled monocytes produced in time period 0to t, I = labeling index,
Nun, = totalnumber of bone marrow monocytes, Nb, = totalnumber of blood monocytes, t = time, k
= exponential disappearance rate constant of monocytes from the peripheral blood, and fo` (Ib, x
NbJ1 -- area under the curve of the numbers of labeled blood monocytes from t = 0 to t = t. In the
azathioprine experiments k values were taken as determined in similar experiments without drug
treatment (4): for mice treated with azathioprine alone k = 0.03974 h-', and for azathioprine-treated
mice with an acuteinflammation k = 0.06946 h-'forthefirst24 h and thereafter k = 0.03974 h-`.
Identification of the Cells. The criteria used for the morphological characterization of the
promonocytes, bone marrow monocytes, and peripheral blood monocytes have been described
elsewhere (3, 5).
Results
The Effect of Azathioprine on the Number ofPromonocytes and Bone Marrow
Monocytes. Since the number of monocytes in the peripheral blood decreases
during treatment with azathioprine,) it was of interest to study the effect of this
drug on the number of monocytes and promonocytes in the bone marrow
compartment.
Treatment of mice for 4 days with 200 mg/kg azathioprine showed that the
number of promonocytes increased during the first 48 h from 3.86 x 10'to 5.86 x
10' cells/femur, and then decreased to 2.38 x 10" at 96 h, or 24 h after the last
azathioprine injection (Fig. 1) . When the animals were treated with 3 mg/kg
azathioprine for a period of 9 days, the number of promonocytes remained con-
stant (Fig. 1) .
The number of bone marrow monocytes in mice treated with 200 mg/kg
azathioprine decreased from 23.76 x 10' to 5.95 x 10" monocytes/femur at 96 h,
which is 37.5% of the normal value. After azathioprine administration was
stopped, the number of monocytes increased gradually (Fig. 1). When the
animals were treated longer than 4 days with this high dose of azathioprine the
number of monocytes dropped to 0.2 x 10'/femur at 216 h. The numbers of
nucleated cells in these samples were too low for reliable differential counts and
therefore the monocyte-to-promonocyte ratio in the 6-h bone marrow culture
could not be determined. During the treatment with 3 mg/kg azathioprine the
number of bone marrow monocytes decreasedgradually, reaching its lowest value
(i.e., 10.73 x 10" monocytes/femur) at 216 h (Fig. 1) .534
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The effect of treatment with 200 mg/kg (-) or 3 mg/kg (----) azathioprine on the
numbers of promonocytes and bone marrow monocytes.
The Effect ofAzathioprine on theIn Vitro andIn Vivo [9H]ThymidineLabeling
ofPromonocytes. Since it is known that azathioprine inhibits cellularprolifera-
tion and causes a decrease in the number of both peripheral blood and bone
marrow monocytes, azathioprine would be expected to inhibit the mitotic activity
of the direct precursor of the monocytes, the promonocyte. To investigate this
point, the effect of this drug on the percentage of promonocytes synthesizing
DNA was determined .
First the effect of azathioprine added in vitro to bone marrow cultures from
normal mice incubated in the presence of 0.1 /Ci/ml ['H]thymidine was studied.
Since in vivo azathioprine is converted into 6-mercaptopurine, i.e. the active
antimetabolic compound, similar cultures were prepared with this drug. The
effect of both drugs on the labeling index of peritoneal macrophages was also
determined. The results show that neither azathioprine nor 6-mercaptopurine
added in vitro affected the labeling index of the promonocytes and monocytes in
6-h bone marrow cultures (Table I). Also, there was no decrease in the labeling
index of peritoneal macrophages cultured for 2 h except in the cultures with 30
jug/ml azathioprine (Table I); longer incubation (24 h) made no difference.
Next, bone marrow samples from mice treated for 1-4 days with 200 mg/kg
azathioprine were incubated for 6 h in the presence of 0.1 uCi/ml [9H]thymidine.
In normal animals the in vitro labeling index of the promonocytes amounted to
50.9%. During azathioprine treatment, significantly (P < 0.001) higher labeling
indices (between 93.7 and 92.3%) were found from 72 to 120 h; when treatment
was stopped, these indices decreased (Fig. 2 a).
In animals treated for 9 days with a low dose of azathioprine (3 mg/kg) the in
vitro labeling indices also increased significantly (P < 0.001), reaching 84.1 and
90.0% after the 5th day of treatment (Fig. 2 b). To verify this increase of the. in
vitro labeling index, a similar experiment was performed in which cell labeling
was done in vivo. Mice treated with the high dose (200 mg/kg) of azathioprineVAN FURTH, GASSMANN, AND DIESSELHOFF-DEN DULK
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received 1 pCi/g [aH]thymidine intravenously 1 h before they were killed. The
results demonstrate that the in vivo labeling indices of the promonocytes were
also significantly (P < 0.001) increased, the highest value being 92.0% at 96 h
(Fig. 2 c).
These results are contrary to expectation, since nodecrease due to inhibition of
DNA synthesis occurred in the promonocyte-labeling index during in vivo
treatment with azathioprine. Because azathioprine does not lower the number of
promonocytes in the bone marrow either, these results mean that the total
TABLE I
The Effect of Azathioprine and 6-Mercaptopurine on the In Vitro Labeling of
Promonocytes, Bone Marrow Monocytes, and Peritoneal Macrophages
Concentration
ofdrug in
medium
* Cultured for 6 h in medium with 0.1 pCi/ml ['H]thymidine.
$ Cultured for 2 h in medium with 0.1 yCi/ml ['H]thymidine.
u,
ar
u
0
c
0
E
0
n
AgIml
0
0.3
3.0
30.0
0
i
14 1 1 200mg/kg azathioprine j j j j + + + j + 3mg/kg azathioprine
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The effect of treatment with 200 mg/kg or 3 mg/kg azathioprine on the labeling index
of promonocytes after 6 h of incubation with ['Hlthymidine (a and b), and 1 h after an
intravenous injection with [3Hlthymidine (c).
Labeled
promonocytes
*
Azathioprine
Labeled
bone marrow
monocytes*
Labeled
peritoneal
macrophages$
Labeled
pr°monocytes
6-mercaptopurine
Labeled
* bone marrow
monocytes*
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peritoneal
macrophages$
% % % % %
50.3 0.4 3.0 50.8 0.5 2.8
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number of promonocytes synthesizing DNA is not reduced by azathioprine
treatment. Since the production of monocytes is inhibited, it is likely that this
drug affects the cell cycle of promonocytes at another and later stage. It was
therefore relevant to determine the DNA synthesis time and cell cycle time of
these cells.
The Effect ofAzathioprine on theDNA Synthesis Time and Cell Cycle Time of
the Promonocytes. The method used to determine the DNA synthesis time
from the percentages of labeled promonocytes after three intravenous injections
of 1 uCi/g [9H]thymidine given precisely 1 h apart, has been described previously
(4) and the results pertaining to normal mice were taken from that publication.
It was again clear that during treatment with azathioprine the labeling index 1
h after the first [eH]thymidine injection (i) was higher than in normal mice
(Table 11). The hourly increment of the labeling index (Ai) was reduced during
treatment with azathioprine .
TABLE 11
DNA-Synthesis Time (t8) and Cell-Cycle Time (t,) in the Normal Steady State and
During Treatment with Azathioprine*
i, initial labeling index of promonocytes 1 h after first injection of ['H]thymidine; Ai, mean hourly
increment of promonocyte-labeling index after second and third injections of ['H]thymidine; tB,
i/Ai; and t,, to x 100/i .
* Mice labeled with 1, 2, or 3 intravenous injections of 1 uCi/g ['H]thymidine.
§ Time after intraperitoneal injection of 1 ml NBCS .
11 Duration of azathioprine .
t From reference 4.
The DNA-synthesis time of the promonocytes (t,,) was computed by dividing
the initial labeling index by the increment of the labeling index per hour (i/Di)
(10). In mice treated with 3 mg/kg azathioprine the DNA synthesis time was
significantly (P < 0.001) prolonged, on the average by 6 h, and mice treated with
200 mg/kg azathioprine had an extremely long DNA synthesis time (Table II).
The cell cycle time of the promonocyte (t,) was computed by dividing the
DNA-synthesis time by the initial labeling index (t8 x 100/i) . During treatment
with 3 mg/kg azathioprine the cell cycle time was on the average 5.7 h longer than
in normal mice (Table II). Application of this calculation to the data from the
animals treated with the high dose of azathioprine would give extremely long
generation times, which are meaningless. The results of these experiments show
unequivocally that during treatment with azathioprine the DNA sysnthesis time
Normal
steady
Acute
inflammation$
Azathioprine
(200 mg/kg)
Azathioprine
(3 mg/kg)
Azathioprine
(3 mg/kg; 96 hr)
in-
state$
12 h§ 24 h§ 48h1l 96h1l 96h1l 192h11
+ acute
flammation
(12) §
i 72.9% 69.8% 76.7% 83.6% 91.6% 81.7% 81.4% 81.5%
Ai 6.2% 9.2% 6.0% 1.0% 0.4% 4.4% 4.8% 5.1%
4 11.8 h 7.6 h 12.8 h 83.6 h 229.0 h 18.6 h 17.0 h 16.0 h
t~ 16.2 h 10.8 h 16.7 h (100.0 h) (250.0 h) 22.8 h 20.9 h 19.6 hVAN FUATH, GASSMANN, AND DIESSELHOFF-DEN DULK
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of the promonocytes is prolonged, thus making the cell cycle time significantly
(P < 0.001) longer.
Cytophotometric Determination of the DNA Content of Promonocytes and
BoneMarrowMonocytes. Since azathioprine causes a prolongation oftheDNA
synthesis time and thus retards the mitotic activity ofthe promonocytes it wasof
interest to find out whether the bone marrow ofthese animals had an increased
number ofpromonocytes with a tetraploid DNA content.
Cytophotometric determination of the Feulgen-DNA content ofnuclei of bone
marrow monocytes and promonocytes was done in normal mice and in mice
treated for 96 h with 200mg/kgazathioprine. Compared with thediploid standard
ofthe granulocytes in the same preparation, the nuclei ofthe monocytes in all of
thesamples had a diploid DNA content. In normal mice 15%ofthe promonocytes
showed a diploid content of Feulgen-DNA, 42.5% lay higher than diploid and
lower than tetraploid, and 42.5% were tetraploid (Fig. 3).
The azathioprine-treated mice showed a gradual decrease in the percentage of
diploid promonocytes (at 96 h none of the promonocytes had a diploid
Normal
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144 h
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Fin. 3. The effect of treatment with 200 mg/kg azathioprine (given up to 96 h) on the
Feulgen-DNA content of the promonocytes, expressed in AU. At 48, 72, and 96 h the
percentage of tetraploid promonocytes (about 200 AU Feulgen-DNA) was significantly
increased (P < 0.01). After azathioprine treatment was stopped, the percentage of diploid-
promonocytes (about 100 AU) increased.538
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Feulgen-DNA content) . The percentage of promonocytes with a tetraploid or
higher Feulgen-DNA value gradually increased to 60% at 72 h. The samples
taken at 192 h, when azathioprine treatment had been stopped for 96 h, showed
12.5% of the promonocytes to have a diploid and 32.5% a tetraploid Feulgen-DNA
value (Fig. 3) . Statistical analysis (rank order test) showed that the increase in
the Feulgen-DNA content of the promonocytes between 48 and 96 h was
significant (P G 0.001). The results of this cytophotometric study thus confirm
the conclusion that during azathioprine treatment the promonocytes synthesize
DNA, and indicate that after DNA synthesis the cells do not proceed via the
G2-phase to mitotic division.
In Vivo Labeling with ['H]Thymidine During Azathioprine Treatment.
￿
La-
beling of promonocytes and monocytes was studied in mice treated for 4 days with
200 mg azathioprine and given a single intravenous injection of 1 yCi/g
['H]thymidine 1 h before the first dose of azathioprine. The labeling index of the
promonocytes increased from 75% at 1 h to 80% at 24 h after ['H]thymidine ad-
ministration and then decreased, which is in agreement with the results of
in vitro ['H]thymidine labeling (Fig. 2 a) and those obtained in the labeling
experiment performed to determine the DNA synthesis time (Table II).
The total number of labeled promonocytes per mouse, computed with the
labeling indices and total number of cells (calculated with data from Fig. 1),
increased during the first 24 h and then leveled off, which is quite different from
the course found in normal animals (Fig. 4) . The increase in the total number of
labeled bone marrow and peripheral blood monocytes in these animals, calcu-
lated with the labeling indices and total number of cells per mouse (calculated
with data from Fig. 1 and footnote 1), was considerably lower than the increase
in normal animals (4) (Fig. 4), indicating a decreased monocyte production.
The Effect of Azathioprine on Monocyte Production .
￿
With the data of the
previous experiment (Fig. 4) the monocyte production during treatment with 200
mg/kg azathioprine is calculated to be 65.3 x 10` cells during the first 24 h; after
that, monocyte production is virtually arrested.
In the next experiment monocyte production was studied after 4 days of
FIG. 4.
￿
The effect of treatment with 200 mg/kg azathioprine (-) on the total number of
labeled promonocytes, bone marrow monocytes, andperipheral blood monocytes, when 1,uCi/g
['H]thymidine was given intravenenously 1 hbefore the first dose of azathioprine. The data for
the normal mice (----) are taken from reference 4.treatment with 200 mg/kg azathioprine . In these mice, which were given an
intravenous injection of 1 uCi/g ['H]thymidine 1 h after the last dose of
azathioprine, the total number of labeled monocytes in the bone marrow and
peripheral blood (Fig. 5) was considerably lower than that found in normal mice
(4). The total production of labeled monocytes calculated with these data
amounted to 10.0 x 10` cells during the first 24 h and continued to increase (Fig.
5), but remained more than 90% lower than in normal mice (5).
Since treatment with a high dose of azathioprine considerably reduced the
production ofmonocytes, the effect of a low dose was studied. Mice were treated
daily with 3 mg/kg azathioprine and after 4 days received an intravenous
injection of 1 ACi/g ['H]thymidine. The monocyte production (calculated from
the labeling indices and total number of bone marrow and peripheral blood
monocytes) amounted to 1.18 x 108 cells during the first 24 h after labeling,
which is 75% of the production in normal mice (Fig. 6). After that, monocyte
production did not increase any further, in contrast to normal mice.
The Effect of Azathioprine on Monocyte Production during an Acute Inflam-
matory Reaction. Since treatment with 3 mg/kg azathioprine reduced the
number of mononuclear phagocytes in an inflammmatory exudate' and also
diminished the monocytosis' usually occurring during such an inflammatory
response (4, 5) we investigated monocyte production under these conditions.
Mice undergoing the same treatment as in the preceding experiment were given
an intraperitoneal injection of NBCS 1 h after the ['H ]thymidine injection. In
these animals the calculated monocyte production amounted to 1.17 x 108 cells
during the first 24 h and thereafter increased slightly (Fig. 6). At 96 h the
difference between this monocyte production and that of azathioprine-treated
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Total production of labeled monocytes after treatment with 200 mg/kg azathioprine.
A single intravenous injection of 1 uCi/g ['H]-thymidine was given 1 h after the last dose of
azathioprine. The influx of monocytes into the peripheral blood is the sum of the labeled
peripheral blood monocytes and the number of labeled monocytes that have left the
circulation. The total production of labeled monocytes is the sum of the number of labeled
bone marrow monocytes and the total influx of monocytes into the peripheral blood.540
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mice without an inflammatory reaction was not significant but the production
was much lower than that found during an inflammatory reaction in untreated
mice (Fig. 6).
To obtain more information about the effect of azathioprine on monocyte
production during an acute inflammation, the phases of the cell cycle of the
promonocytes were determined, as described above, 12 h after an acute
peritoneal inflammation had been provoked with NBCS in mice treated for 4
days with 3 mg/kg azathioprine . Here, the DNA synthesis time amounted to 16.0
h and the cell cycle time to 19.6 h (Table II). Both ofthesevalues are very similar
to those obtained in mice given only 3 mg/kg azathioprine, but are significantly
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FiG. 6. Total production of labeled monocytes in mice treated daily with 3 mg/kg
azathioprine, with and without an acute inflammatory reaction provoked with an intraperito-
neal injection of 1 ml NBCS given 1 hafter the ['H]thymidine. Thesingle injection of 1 J1Ci/g
['H]thymidine was given after 4 days of pretreatment with azathioprine. For comparison, the
findings in the absence of azathioprine (from reference 4) are given.
(P < 0.001) longer than those in normal mice with a provoked inflammatory
reaction (Table II). With the number of promonocytes (4.56 x 101 cells/mouse)
found at the 12th h of the inflammatory response in azathioprine-treated mice
and the cell cycle time of the promonocytes, the monocyte production was
calculated (4) to be 0.47 x 106 monocytes/h (Table III).
The main conclusion to be drawn from this study is that azathioprine reduces
the formation of monocytes in the bone marrow because this drug stronglyVAN FURTH, GASSMANN, AND DIESSELHOFF-DEN DULK
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TABLE III
The Effect of Azathioprine on the Rate of Monocyte Production
R, production rate; P., total number of labeled monocytes produced in time period 0 to t; N,_,
total number of promonocytes; t, time; and t,, cell cycle time.
* R = Po_Jt.
$R = 2 x N,,./t,.
§ Intraperitoneal injection of 1 ml NBCS at 0 h.
11 200 mg/kg azathioprine sc daily.
1f 3 mg/kg azathioprine se daily.
** Intraperitoneal injection of 1 ml NBCS after 4-day pretreatment with azathioprine.
inhibits the mitotic activity of the promonocytes. The mechanism underlying
this effect on the promonocytes is as follows: although these cells still synthesize
DNA, this phase of the cell cycle is prolonged, the cell cycle of the promonocytes
is arrested late in the DNA synthesis phase or in the postsynthesis phase, called
the G2 phase, and the next phase, mitosis, does not occur.
What observations support this conclusion? In animals treated with azathio-
prine the number of monocytes in the peripheral blood' and bone marrow
decreases. However, the effect of azathioprine is reversible, since the number of
monocytes in the bone marrow and peripheral blood rises again after administra-
tion of the drug has been stopped. The in vivo labeling studies show that the
formation of labeled monocytes is reduced in dependence on the duration of the
administration of the drug: 24 h after a high dose ofazathioprine the production
is still 50%ofthat in normal mice, but after 4days this value has dropped to 10%.
A reduced monocyte production could be expected to result from a diminished
mitotic activity of the promonocytes and a significantly prolonged cell cycle time
was indeed found in azathioprine-treated animals. In the low dose treatmentthis
prolongation was about 5.5 h; in the high dose treatment extremely long
generation times were estimated.
It is of interest that the intervention of this drug in the cell cycle of the
Conditions Period
Monocyte
Calculation A*
production
Calculation B$
x10°/h x10'/h
Normal 0.65 0.62
Acute Inflammation § 0-12 1.06
12-24 0 .78
at 12 0.96
at 24 0.70
High dose azathioprinell 0-24 0.27
72-96 0.04
Low dose azathioprine4 72-96 0.49
at 96 0.47
Lowdose azathioprine** and 0-24 0.49
acute inflammation** at 12 0.47542
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promonocytes could be localized. In azathioprine-treated animals the number of
promonocytes increased initially, which is compatible with aprolonged cell cycle
time of these cells. Furthermore, in the in vivo and in vitro labeling experiments
with [9H]thymidine the labeling indices were significantly higher than those in
normal mice. This was unexpected, because if this drug inhibits DNA synthesis
(1, 2), lower values should be found. Determination of the DNA synthesis time
demonstrated that the DNA synthesis phase of the cell cycle was prolonged in
azathioprine-treated mice with and without an acute inflammation. Cytopho-
tometric analysis next demonstrated a significantly higher percentage of promon-
ocytes with a tetraploid DNA content. All of these findings lead to the conclusion
that during azathioprine treatment the promonocytes pass through the DNA
synthesis phase of the cell cycle but are then arrested near the end of the DNA
synthesis phase or in the G, phase.
These in vivo observations on the time of the effect of azathioprine in the cell
cycle of the promonocytes seem to be novel. This drug and6-mercaptopurine also
reduce the numbers of other categories of leukocytes (e.g., granulocytes and
lymphocytes) (references 11-16 and footnote 1) but no detailed analysis of how
this effect occurs in vivo has been published as yet. For the mixed lymphocyte
reaction it has been reported that 10 ug/ml azathioprine inhibits the incorpora-
tion of [9H]thymidine in vitro, whereas a 10 times higher concentration is
cytotoxic (17) . However, the authors mention a stimulation of the incorporation
of this label when very low concentrations (0.1 and 0.001,ug/ml) were used. In the
presentstudy the addition of azathioprine to bone marrow cultures did not affect
DNA synthesis. Another communication describes the inhibition of in vitro DNA
synthesis of mouse spleen cells by azathioprine, but does not throw light on the
mode of action of this drug on the cells (18) . In vivo administration of
azathioprine was also found to inhibit DNA synthesis by spleen, kidney,
duodenum, thymus, lymph node, and normal liver cells in rats (19) . Of interest
there is the observation that the administration of azathioprine suppresses the
stimulation of DNA synthesis in liver cells after partial hepatectomy, but the
regenerating liver of these rats showed a population of liver cells apparently in
the G2 phase that were stimulated to divide (19) . This finding again indicates
that azathioprine blocks the cell cycle just before or in the G, phase, as was found
in the present study, but liver cells in the G.- phase can apparently proceed to the
mitosis phase. A similar effect on the cell cycle was observed in a transplantable
carcinoma in rabbits (20), epithelial cells of the small intestine of mice (21), and
cultures of Chinese hamster cells treated with bleomycin (22, 23); in Ehrlich
tumor cells in mice (24, 25), mouse fibroblast cultures (25), HeLa cells (26) and
Chinese hamster cells (26) treated with nitrogen mustard; in cultured human
leukocytes (27), and Ehrlich ascites tumor cells in mice (28) treated with rubido-
mycin (daunomycin) ; and in fibroblast cultures exposed to melphalan (29), mito-
mycin C (29), and myeleran (30) .
The rate of monocyte production during azathioprine treatment can be
computed according to two methods (A and B) (Table III), as had been done
previously for the normal steady state and an acute inflammatory response (4).
Comparison shows that after 24 h of treatment with a high dose of azathioprine
the rate of monocyte production is about 40% and after 96 h is less than 10% of theVAN FURTH, GASSMANN, AND DIESSELHOFF-DEN DULK
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rate in the normal steady state . Treatment with a low dose of azathioprine only
gives a reduction of 20%, but when an acute inflammation is provoked the rate of
monocyte production does not increase as in animals not treated with
azathioprine (Table III) . The calculations (B) based on the total number of
promonocytes and the promonocyte cell cycle time during treatment with 3
mg/kg azathioprine agree very well with the rate of monocyte production derived
from the completely independent experimental data on total monocyte produc-
tion (Table III) . This agreement once again confirms our earlier conclusion (3, 4)
that the division of one promonocyte gives rise to two monocytes, since
calculation B is based on this premise .
Insight into the kinetics of the mononuclear phagocytes during azathioprine
treatment can be obtained by comparing the data on the total production of
labeled monocytes, the influx of monocytes into and their efflux from the
peripheral blood compartment, and the migration of labeled monocytes into the
peritoneal cavity (taken from footnote 1), with corresponding data obtained
during the normal steady state and acute inflammatory reaction (4) (Fig . 7) .
From this comparison it is evident that treatment with 3 mg/kg azathioprine
considerably reduces monocyte production, and that fewer labeled monocytes
enter and leave the circulation . During an inflammatory response in these
azathioprine-treated animals, monocyte production is not augmented but the
passage of these cells through the circulation is slightly accelerated . The number
of labeled monocytes produced and transported through the circulation, is,
however, considerably lower than during an acute inflammatory response in
animals without azathioprine .
Not only do fewer cells leave the circulation, but in addition, only 10% of these
monocytes arrive in the inflammatory exudate in the peritoneal cavity of
azathioprine-treated animals ; in animals without azathioprine and with an
inflammatory reaction, 40% of the cells leaving the circulation migrate to the site
of inflammation . This might indicate that azathioprine not only affects mono-
BONE MARROW
￿
PERIPHERAL BLOOD
￿
TISSUES
peritoneal cavity
2 0 .10 5
Present
11 18 h
0 .6 . 105
macrophages
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macrophages
0 .1 x 10 5
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macrophages
r
￿
other tissues
FIG . 7 .
￿
The total production of labeled monocytes in the bone marrow, their transit through
the peripheral blood compartment, and their migration into the peritoneal cavity during
treatment with a low dose (3 mg/kg) of azathioprine and during an acute inflammation in
azathioprine-treated mice . For comparison, the course during the normal steady state and an
acute inflammation (data from reference 4) is indicated .
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cyte production but also affects the formation of a cellular exudate at the site of
the inflammation in a different way.
The effect of azathioprine on monocyte production is quite different from the
effect of another category of drug, namely glucocorticosteroids, which also affect
the inflammatory reaction . The latter only inhibits promonocyte division and
monocyte production slightly (about 20%), but cause an impaired release ofthese
cells from the bone marrow into the circulation (31). Glucocorticosteroids also
cause monocytopenia in the peripheral blood, most probably by a sequestration
ofthese cells in a still unknown pool (32). During an acute inflammatory response
in glucocorticosteroid-treated animals there is little augmentation (20%) of the
production of monocytes (unpublished observation), there is no monocytosis
caused by recruitment ofcellsfrom the bone marrow, andthe influx ofmonocytes
into the site oflesion is markedly (90%) reduced (32). The difference between the
mechanisms underlying the action of glucocorticosteroids (31, 32) and azathio-
prine may lead to an additive effect of these drugs, which are widely used in
combination because of their anti-inflammatory and immunosuppressive ac-
tions.
Summary
The present communication concerns the effect of azathioprine on the mitotic
activity of promonocytes and the production of monocytes. In vitro and in vivo
labeling with [9H]thymidine showed that during azathioprine treatment the
promonocytes synthesize DNA and that, contrary to expectation, the labeling
index increases. Cytospectrophotometric determination of the Feulgen-DNA
content of the promonocytes during azathioprine treatment showed an increase
in the percentage of tetraploid promonocytes, and determination of the various
phases of the cell cycle showed significantly increased DNA synthesis and cell
cycle times as compared with the normal steady state.
On the basis of these results it can be concluded that azathioprine arrests the
cell cycle of the promonocytes late in the DNA synthesis phase or in the
postsynthesis (GZ) phase and mitosis does not occur. This timing of the effect of
azathioprine had not been previously observed.
The diminished mitotic activity of the promonocytes during azathioprine
treatment depressed monocyte production. During treatment with 3 mg/kg
azathioprine the cell cycle time of the promonocytes was on the average 5.5 h
longer than in the normal steady state and the rate of monocyte production was
reduced by 70%.
During an acute inflammatory reaction too, monocyte production is affected
by azathioprine . In animals not treated with azathioprine but with an acute
inflammation the cell cycle time becomes shorter and the monocyte production
increases, but animals treated with (3 mg/kg) azathioprine do not show this
effect.
The kinetics of the monocyte also changes under the low dosage of azathio-
prine. As consequence of the diminished production of monocytes, far fewerVAN FURTH, GASSMANN, AND DIESSELHOFF-DEN DULK
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(about 50%) monocytes enter and leave the circulation than during the normal
steady state. During an acute inflammatory reaction the numbers in transit
through the circulation are slightly augmented but remain considerably lower
than in nonazathioprine-treated animals. As a result, the inflammatory exudate
contains 70% less macrophages than that of animals not treated with azathio-
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determinations in the Laboratory for Histology of the University of Amsterdam.
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